{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T14:20:03Z","timestamp":1753885203564},"reference-count":13,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2005,10,1]],"date-time":"2005-10-01T00:00:00Z","timestamp":1128124800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinica Chimica Acta"],"published-print":{"date-parts":[[2005,10]]},"DOI":"10.1016\/j.cccn.2005.04.036","type":"journal-article","created":{"date-parts":[[2005,8,23]],"date-time":"2005-08-23T18:13:13Z","timestamp":1124820793000},"page":"103-107","source":"Crossref","is-referenced-by-count":16,"title":["Enzyme replacement therapy for Fabry disease: Morphologic and histochemical changes in the urinary sediments"],"prefix":"10.1016","volume":"360","author":[{"given":"Kouichi","family":"Utsumi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Futoshi","family":"Mitsuhashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koichi","family":"Asahi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Makoto","family":"Sakurazawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazumasa","family":"Arii","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuichi","family":"Komaba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshiya","family":"Katsumata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ken-Ichiro","family":"Katsura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryoichi","family":"Kase","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuo","family":"Katayama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cccn.2005.04.036_bib1","series-title":"The metabolic and molecular bases of inherited disease","first-page":"3733","article-title":"\u03b1-Galactosidase a deficiency: Fabry disease","author":"Desnick","year":"2001"},{"key":"10.1016\/j.cccn.2005.04.036_bib2","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s101570050061","article-title":"Fabry disease in patients receiving maintenance dialysis","volume":"4","author":"Utsumi","year":"2000","journal-title":"Clin Exp Nephrol"},{"key":"10.1016\/j.cccn.2005.04.036_bib3","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1046\/j.1523-1755.2003.00160.x","article-title":"Fabry disease: detection of undiagnosed hemodialysis patients and identification of a \u201crenal variant\u201d phenotype","volume":"64","author":"Nakao","year":"2003","journal-title":"Kidney Int"},{"key":"10.1016\/j.cccn.2005.04.036_bib4","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1056\/NEJM197104082841401","article-title":"Diagnosis of glycosphingolipidoses by urinary-sediment analysis","volume":"284","author":"Desnick","year":"1971","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cccn.2005.04.036_bib5","first-page":"24","article-title":"Immunohistochemical localization of glycosphingolipid in urinary renal tubular cells in Fabry's disease","volume":"82","author":"Chatterjee","year":"1984","journal-title":"AJCP"},{"key":"10.1016\/j.cccn.2005.04.036_bib6","doi-asserted-by":"crossref","first-page":"2743","DOI":"10.1001\/jama.285.21.2743","article-title":"Enzyme replacement therapy in Fabry disease: a randomized controlled trial","volume":"285","author":"Schiffmann","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.cccn.2005.04.036_bib7","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1056\/NEJM200107053450102","article-title":"Safety and efficacy of recombinant human alpha-galactosidase replacement therapy in Fabry's disease","volume":"345","author":"Eng","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cccn.2005.04.036_bib8","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/0009-8981(81)90384-3","article-title":"Differential assay for lysosomal alpha-galactosidases in human tissues and its application to Fabry's disease","volume":"112","author":"Mayes","year":"1981","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.cccn.2005.04.036_bib9","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1111\/j.1399-0004.1993.tb03905.x","article-title":"Immunofluorescence imaging diagnosis of Fabry heterozygotes using confocal laser scanning microscopy","volume":"44","author":"Itoh","year":"1993","journal-title":"Clin Genet"},{"key":"10.1016\/j.cccn.2005.04.036_bib10","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1006\/abbi.1994.1144","article-title":"Generation of one set of murine monoclonal antibodies specific for globo-series glycolipids: evidence for differential distribution of the glycolipids in rat small intestine","volume":"310","author":"Kotani","year":"1994","journal-title":"Arch Biochem Biophys"},{"key":"10.1016\/j.cccn.2005.04.036_bib11","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s10545-005-5263-4","article-title":"Measurement of urinary CDH and CTH by tandem mass spectrometry in patients hemizygous and heterozygous for Fabry disease","volume":"28","author":"Mills","year":"2005","journal-title":"J Inherit Metab Dis"},{"key":"10.1016\/j.cccn.2005.04.036_bib12","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1093\/clinchem\/29.8.1494","article-title":"Enzymic creatine assay: a new colorimetric method based on hydrogen peroxide measurement","volume":"29","author":"Fossati","year":"1983","journal-title":"Clin Chem"},{"key":"10.1016\/j.cccn.2005.04.036_bib13","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s10545-005-4415-x","article-title":"Monitoring enzyme replacement therapy in Fabry disease\u2014role of urine globotriaosylceramide","volume":"28","author":"Whitfield","year":"2005","journal-title":"J Inherit Metab Dis"}],"container-title":["Clinica Chimica Acta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898105002937?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898105002937?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,4,9]],"date-time":"2020-04-09T05:04:32Z","timestamp":1586408672000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009898105002937"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,10]]},"references-count":13,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2005,10]]}},"alternative-id":["S0009898105002937"],"URL":"https:\/\/doi.org\/10.1016\/j.cccn.2005.04.036","relation":{},"ISSN":["0009-8981"],"issn-type":[{"value":"0009-8981","type":"print"}],"subject":[],"published":{"date-parts":[[2005,10]]}}}